Literature DB >> 20018753

Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding.

Swaine L Chen1, Chia S Hung, Jerome S Pinkner, Jennifer N Walker, Corinne K Cusumano, Zhaoli Li, Julie Bouckaert, Jeffrey I Gordon, Scott J Hultgren.   

Abstract

FimH, the type 1 pilus adhesin of uropathogenic Escherichia coli (UPEC), contains a receptor-binding domain with an acidic binding pocket specific for mannose. The fim operon, and thus type 1 pilus production, is under transcriptional control via phase variation of an invertible promoter element. FimH is critical during urinary tract infection for mediating colonization and invasion of the bladder epithelium and establishment of intracellular bacterial communities (IBCs). In silico analysis of FimH gene sequences from 279 E. coli strains identified specific amino acids evolving under positive selection outside of its mannose-binding pocket. Mutating two of these residues (A27V/V163A) had no effect on phase variation, pilus assembly, or mannose binding in vitro. However, compared to wild-type, this double mutant strain exhibited a 10,000-fold reduction in mouse bladder colonization 24 h after inoculation and was unable to form IBCs even though it bound normally to mannosylated receptors in the urothelium. In contrast, the single A62S mutation altered phase variation, reducing the proportion of piliated cells, reduced mannose binding 8-fold, and decreased bladder colonization 30-fold in vivo compared to wild-type. A phase-locked ON A62S mutant restored virulence to wild-type levels even though in vitro mannose binding remained impaired. Thus, positive selection analysis of FimH has separated mannose binding from in vivo fitness, suggesting that IBC formation is critical for successful infection of the mammalian bladder, providing support for more general use of in silico positive selection analysis to define the molecular underpinnings of bacterial pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20018753      PMCID: PMC2794649          DOI: 10.1073/pnas.0902179106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Chaperone priming of pilus subunits facilitates a topological transition that drives fiber formation.

Authors:  Frederic G Sauer; Jerome S Pinkner; Gabriel Waksman; Scott J Hultgren
Journal:  Cell       Date:  2002-11-15       Impact factor: 41.582

2.  Intracellular bacterial biofilm-like pods in urinary tract infections.

Authors:  Gregory G Anderson; Joseph J Palermo; Joel D Schilling; Robyn Roth; John Heuser; Scott J Hultgren
Journal:  Science       Date:  2003-07-04       Impact factor: 47.728

3.  Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.

Authors:  M A Mulvey; J D Schilling; S J Hultgren
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection.

Authors:  Chia-Suei Hung; Julie Bouckaert; Danielle Hung; Jerome Pinkner; Charlotte Widberg; Anthony DeFusco; C Gale Auguste; Robert Strouse; Solomon Langermann; Gabriel Waksman; Scott J Hultgren
Journal:  Mol Microbiol       Date:  2002-05       Impact factor: 3.501

5.  CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli.

Authors:  Joel D Schilling; Steven M Martin; David A Hunstad; Kunal P Patel; Matthew A Mulvey; Sheryl S Justice; Robin G Lorenz; Scott J Hultgren
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

6.  Host-symbiont conflicts: positive selection on an outer membrane protein of parasitic but not mutualistic Rickettsiaceae.

Authors:  Francis M Jiggins; Gregory D D Hurst; Ziheng Yang
Journal:  Mol Biol Evol       Date:  2002-08       Impact factor: 16.240

7.  Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis.

Authors:  Sheryl S Justice; Chia Hung; Julie A Theriot; Daniel A Fletcher; Gregory G Anderson; Matthew J Footer; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-22       Impact factor: 11.205

8.  Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli.

Authors:  Ruth E Berry; David J Klumpp; Anthony J Schaeffer
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

9.  The FimH A27V mutation is pathoadaptive for urovirulence in Escherichia coli B2 phylogenetic group isolates.

Authors:  Florence Hommais; Stéphanie Gouriou; Christine Amorin; Hung Bui; Mohamed Chérif Rahimy; Bertrand Picard; Erick Denamur
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli.

Authors:  Joel D Schilling; Steven M Martin; Chia S Hung; Robin G Lorenz; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

View more
  84 in total

1.  Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Corinne K Cusumano; Thomas J Hannan; James W Janetka; Scott J Hultgren
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

Review 2.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

Review 3.  Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.

Authors:  David G Thanassi; James B Bliska; Peter J Christie
Journal:  FEMS Microbiol Rev       Date:  2012-05-24       Impact factor: 16.408

4.  What does it take to stick around? Molecular insights into biofilm formation by uropathogenic Escherichia coli.

Authors:  Maria Hadjifrangiskou; Scott J Hultgren
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

5.  Structure-based drug design and optimization of mannoside bacterial FimH antagonists.

Authors:  Zhenfu Han; Jerome S Pinkner; Bradley Ford; Robert Obermann; William Nolan; Scott A Wildman; Doug Hobbs; Tom Ellenberger; Corinne K Cusumano; Scott J Hultgren; James W Janetka
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

6.  Androgens Enhance Male Urinary Tract Infection Severity in a New Model.

Authors:  Patrick D Olson; Keith A Hruska; David A Hunstad
Journal:  J Am Soc Nephrol       Date:  2015-10-08       Impact factor: 10.121

Review 7.  Structure, Function, and Assembly of Adhesive Organelles by Uropathogenic Bacteria.

Authors:  Peter Chahales; David G Thanassi
Journal:  Microbiol Spectr       Date:  2015-10

8.  Naturally occurring single amino acid replacements in a regulatory protein alter streptococcal gene expression and virulence in mice.

Authors:  Ronan K Carroll; Samuel A Shelburne; Randall J Olsen; Bryce Suber; Pranoti Sahasrabhojane; Muthiah Kumaraswami; Stephen B Beres; Patrick R Shea; Anthony R Flores; James M Musser
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

9.  Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection.

Authors:  Swaine L Chen; Meng Wu; Jeffrey P Henderson; Thomas M Hooton; Michael E Hibbing; Scott J Hultgren; Jeffrey I Gordon
Journal:  Sci Transl Med       Date:  2013-05-08       Impact factor: 17.956

10.  The UbiI (VisC) Aerobic Ubiquinone Synthase Is Required for Expression of Type 1 Pili, Biofilm Formation, and Pathogenesis in Uropathogenic Escherichia coli.

Authors:  Kyle A Floyd; Courtney A Mitchell; Allison R Eberly; Spencer J Colling; Ellisa W Zhang; William DePas; Matthew R Chapman; Matthew Conover; Bridget R Rogers; Scott J Hultgren; Maria Hadjifrangiskou
Journal:  J Bacteriol       Date:  2016-09-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.